169 related articles for article (PubMed ID: 16912153)
1. Influence of the microenvironment on melanoma cell fate determination and phenotype.
Postovit LM; Seftor EA; Seftor RE; Hendrix MJ
Cancer Res; 2006 Aug; 66(16):7833-6. PubMed ID: 16912153
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
4. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination.
Hendrix MJ; Seftor RE; Seftor EA; Gruman LM; Lee LM; Nickoloff BJ; Miele L; Sheriff DD; Schatteman GC
Cancer Res; 2002 Feb; 62(3):665-8. PubMed ID: 11830517
[TBL] [Abstract][Full Text] [Related]
5. [Histopathological prognostic factors of malignant melanoma].
Plótár V; Orosz Z; Tóth E; Szentirmay Z
Magy Onkol; 2007; 51(1):39-46. PubMed ID: 17417674
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of melanomagenesis and the metastatic phenotype.
Crowson AN; Magro C; Miller A; Mihm MC
Semin Oncol; 2007 Dec; 34(6):476-90. PubMed ID: 18083371
[TBL] [Abstract][Full Text] [Related]
7. Role of nodal signaling and the microenvironment underlying melanoma plasticity.
Postovit LM; Margaryan NV; Seftor EA; Hendrix MJ
Pigment Cell Melanoma Res; 2008 Jun; 21(3):348-57. PubMed ID: 18444961
[TBL] [Abstract][Full Text] [Related]
8. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
9. Toward a molecular classification of melanoma.
Fecher LA; Cummings SD; Keefe MJ; Alani RM
J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
11. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation.
Lee LM; Seftor EA; Bonde G; Cornell RA; Hendrix MJ
Dev Dyn; 2005 Aug; 233(4):1560-70. PubMed ID: 15968639
[TBL] [Abstract][Full Text] [Related]
12. The role of apoptosis in the pathogenesis of malignant melanoma.
Mihić LL; Bulat V; Situm M; Krolo I; Seserko A
Coll Antropol; 2010 Apr; 34 Suppl 2():303-6. PubMed ID: 21302733
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
14. Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities.
Cretu A; Brooks PC
J Cell Physiol; 2007 Nov; 213(2):391-402. PubMed ID: 17657728
[TBL] [Abstract][Full Text] [Related]
15. Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?
van der Rhee JI; Mooi WJ; Kukutsch NA; de Snoo FA; Bergman W
Br J Dermatol; 2010 Feb; 162(2):457-8. PubMed ID: 19919631
[No Abstract] [Full Text] [Related]
16. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
17. BRAF kinase in melanoma development and progression.
DeLuca AM; Srinivas A; Alani RM
Expert Rev Mol Med; 2008 Feb; 10():e6. PubMed ID: 18279546
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
20. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
